Inhibitory action of methylene bisphosphonic acid on metabolic activity and viability of J774A.1 cells
Bisphosphonates (BPs) are primary agents in the current pharmacological arsenal against osteoclast-related bone loss due to osteoporosis, Paget’s disease and bone tumors. Due to the lack of complete understanding of the molecular mechanism of their action in bone tissue and the overlap of key proper...
Saved in:
| Main Authors: | D. O. Labudzynskyi, E. P. Pasichna, O. I. Krynina, М. M. Veliky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
2024-04-01
|
| Series: | The Ukrainian Biochemical Journal |
| Subjects: | |
| Online Access: | http://ukrbiochemjournal.org/wp-content/uploads/2024/04/Labudzynskyi_96_2.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01) -
Zoledronate-induced orbital and ocular inflammation
by: Julia Dyrda, et al.
Published: (2025-03-01) -
Interaction and cellular uptake of surface-modified carbon dot nanoparticles by J774.1 macrophages
by: Lester Thoo, et al.
Published: (2017-10-01) -
Adaptation of mitochondrial bioenergetics to coenzyme Q deficiency in human endothelial cells after chronic exposure to bisphosphonates
by: Adrianna Budzinska, et al.
Published: (2025-05-01) -
Effects of a single intravaneous dose of zoledronic acid on bone healing following tooth extraction in ovariectomized rabbits
by: Esra Mavi, et al.
Published: (2021-11-01)